ProSciento: Julio Gutierrez, VP of clinical research and clinical science
Metabolic disease CRO ProSciento has appointed Julio Gutierrez vice president of clinical research and clinical science. Gutierrez—a board-certified physician in obesity medicine, transplant hepatology, and gastroenterology—will lead the firm’s clinical science team.
“With his deep knowledge of medical research, therapeutic development, and treatment modalities for metabolic diseases, as well as his work for ProSciento as a scientific consultant and principal investigator in early phase NASH clinical trials, he is already making key contributions within our expanding clinical science team,” said Marcus Hompesch, CEO and chair of the board. “In addition to his experience and scientific acumen, Julio has an extraordinary ability to articulate science, whether speaking with our clients, peers in the field, or with patients newly diagnosed.”
